Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria

Liver International

Volumn 28, Issue 8, 2008, Pages 1120-1128

  Woo, Hyun Young ^a   Jang, Jeong Won ^a   Choi, Jong Young ^a   You, Chan Ran ^a   Jeong, Soung Won ^a   Bae, Si Hyun ^a   Yoon, Seung Kew ^a   Lee, Young Sok ^a   Kim, Dong Goo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Milan criteria

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; KOREA; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 48949086007     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01785.x     Document Type: Article

References (36)

1. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207: 373-9.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
3. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy: Hepatology, 1994; 20 (Part 2): 33S-40S.
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
5. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study. Hepatology 1997; 25: 1485-9.
6. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-6.
7. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27: 1572-7.
8. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-22.
9. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-403.
10. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77: 2217-22.
11. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30: 1434-40.
12. Keeffe EB. Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 1998; 4 (Suppl. 1): S108-14.
13. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-83.
14. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-85.
15. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221-8; discussion 28-9.
16. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinom: Are we sure? Liver Transpl 2003; 9: 693-6.
17. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265-72.
18. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan. Ann Surg 2004; 240: 451-9; discussion 59-61.
19. Fuster J, Charco R, Llovet JM, Bruix J, Garcia-Valdecasas JC. Liver transplantation in hepatocellular carcinoma. Transpl Int 2005; 18: 278-82.
20. Lee KW, Park JW, Joh JW, et al. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation? Transpl Proc 2004; 36: 2289-90.
21. Gondolesi GE, Roayaie S, Munoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: Extending UNOS priority criteria. Ann Surg 2004; 239: 142-9.
22. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
23. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
24. Otto G, Herber S, Heise M, et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006; 12: 1260-7.
25. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
26. American Liver Tumor Study Group. A Randomized Prospective Multi-Institutional Trial of Orthotopic Liver Transplantation or Partial Hepatic Resection with or without Adjuvant Chemotherapy for Hepatocellular Carcinoma. Investigator Booklet and Protocol. Washington, DC: National Academies Press, 1998.
27. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10: 911-8.
28. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-51.
29. Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosi: A reasonable strategy? Ann Surg 2003; 238: 508-18.
30. Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001; 7: 631-6.
31. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-9.
32. Millonig G, Graziadei IW, Freund MC, et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007; 13: 272-9.
33. Lopez PM, Villanueva A, Roayaie S, Llovet JM. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal. Liver Transpl 2006; 12: 1747-54.
34. Yang SH, Suh KS, Lee HW, et al. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery 2007; 141: 598-609.
35. Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007; 13: 1637-44.
36. Mazzaferro V. Results of liver transplantation: With or without Milan criteria? Liver Transpl 2007; 13: S44-7.